Lipotropic injections vs semaglutide shots

Lipotropic injections are sold for weight loss, yet none is FDA approved for it, and no randomized trial of them for weight loss appears in PubMed. Semaglutide is the opposite case. In STEP 1, adults without diabetes on weekly brand semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, against 2.4% on placebo (NEJM, 2021).

On lipotropic injections vs semaglutide, the drug with the evidence wins. Harbor's compounded semaglutide is not FDA approved, and STEP 1 tested brand semaglutide, not a compounded version. The guide to how semaglutide works for weight loss explains the mechanism.

One exception matters. If a blood test shows low vitamin B12, a B12 shot is the right call, and semaglutide does not treat it.

Lipo shots and semaglutide shots are both injections, and the likeness ends there. The table compares them on the points that decide a weight loss choice.

Scroll the table sideways to see both columns →

Lipo injections and semaglutide shots part ways on contents, testing and approval.

What is in MIC & lipo B12 injections

MIC injections take their name from three ingredients: methionine (an amino acid), inositol and choline. A review of lipotropes, substances that hasten the removal of fat from the liver, names choline, betaine, myo-inositol, methionine and carnitine as the main ones, with the effect shown in animals (Crit Rev Food Sci Nutr, 2013).

Lipo B12 injections and MIC B12 injections add vitamin B12 to the blend. No lipotropic blend is an FDA-approved product, so no label fixes its recipe or strength, and each seller decides what goes in.

A Wegovy shot holds one active drug, semaglutide, a GLP-1 receptor agonist. Compounded semaglutide is a pharmacy-made product, distinct from Wegovy and Ozempic, and is not FDA approved. The comparison of compounded semaglutide vs Ozempic sets out the differences.

How each one works

Semaglutide is a GLP-1 analogue with 94% sequence homology to the human hormone. The Wegovy label calls GLP-1 a physiological regulator of appetite and caloric intake, and semaglutide acts on its receptors in brain areas that govern appetite (Wegovy prescribing information).

Lipotropes work on a different problem: fat building up in the liver. Choline deficiency can cause liver damage and fatty liver disease, but NIH notes that frank choline deficiency in healthy men and nonpregnant women is very rare (NIH ODS). Correcting a shortage is not the same as adding more. For one serious form of fatty liver disease, noncirrhotic MASH with moderate to advanced fibrosis, brand Wegovy injection has an accelerated FDA approval (Wegovy prescribing information).

B12 matters for a different reason. A lack of vitamin B12 can cause anemia and permanent nerve damage, according to MedlinePlus.

What the weight loss evidence shows

STEP 1 enrolled 1,961 adults with obesity, or overweight plus a weight-related condition, and no diabetes. With diet and activity counseling, 66.1% of people on semaglutide 2.4 mg lost at least 10% of their weight, against 12% on placebo (Wegovy prescribing information). The maker funded the trial, which used brand semaglutide.

For lipotropic shots, the evidence is missing rather than negative. The 2013 review found human intervention studies of lipotropes practically nonexistent, and a PubMed search on November 3, 2026, found no randomized trial of lipotropic injections for weight loss.

B12 has been studied, just not for weight. NIH says it does not provide energy, performance or endurance benefits in people who already get enough (NIH ODS). Neither the cyanocobalamin injection label nor MedlinePlus lists weight loss as a use.

Prescription & FDA status

FDA approved Wegovy, brand semaglutide, for chronic weight management in June 2021. Its label covers adults with obesity, or overweight with at least one weight-related condition. No drug NIH lists as FDA approved for chronic weight management is a lipotropic or vitamin shot (NIDDK).

Compounded drugs are not FDA approved, and FDA does not review them for safety, effectiveness or quality before they are marketed (FDA). That holds for compounded semaglutide and lipotropic blends alike. FDA declared the semaglutide injection shortage resolved in February 2025, and its grace periods for compounders ended in April and May 2025 (FDA). Choline chloride and methylcobalamin sit in Category 1 of FDA's list of bulk substances still under evaluation for compounding (FDA 503A categories).

Cyanocobalamin injection, plain B12, is an FDA-approved prescription drug for B12 deficiency caused by poor absorption, including pernicious anemia (DailyMed label). The guide to NAD shots vs B12 shots covers how B12 shots are used.

Cost & how often each is given

The Wegovy label starts semaglutide at 0.25 mg once a week and raises the dose every 4 weeks toward a usual 2.4 mg maintenance dose. For compounded semaglutide, your clinician sets the dose and schedule. Harbor's program starts at $99 a month and does not rise with your dose.

Lipotropic shots have no FDA label, so no labeled dose, strength or schedule exists. The seller sets the recipe, visits and price, so ask what a full course costs first.

For a deficiency, the MedlinePlus vitamin B12 shot facts describe daily shots for the first 6 to 7 days, then every other day, then every 3 to 4 days, then monthly, sometimes for life.

For weight loss, semaglutide shots are the evidence-based choice. Harbor semaglutide shots are a weekly injection at home for adults, typically with a BMI of 27 or higher, and a board-certified physician reviews your history first. If it is not the right fit, you are not charged.

Semaglutide shots may suit you when:

• You have obesity, or overweight with a weight-related condition such as high blood pressure
• You want a molecule tested in placebo-controlled weight loss trials
• You want one shot a week at home, at a monthly price that stays flat as your dose rises

A lipotropic shot has no proven use for weight loss. A plain B12 shot may be the right call when:

• A blood test shows low B12, or your clinician suspects a deficiency
• You have pernicious anemia, or a low B12 level linked to celiac disease, Crohn's disease or past stomach or bowel surgery, including weight loss surgery
• You eat a vegan diet or take metformin long term, and your B12 level comes back low

Lipotropic injections for weight loss rest on animal studies of liver fat, not human weight loss trials. Semaglutide rests on large placebo-controlled trials of the brand drug, and Harbor offers it as a weekly compounded shot, not FDA approved, after a physician review.

Test your B12 before paying for any vitamin shot. If it is low, B12 is the treatment. If it is normal and weight is the goal, a GLP-1 has the evidence.